Published on in Vol 4, No 7 (2020): July

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/17373, first published .
A Companion App to Support Rheumatology Patients Treated with Certolizumab Pegol: Results From a Usability Study

A Companion App to Support Rheumatology Patients Treated with Certolizumab Pegol: Results From a Usability Study

A Companion App to Support Rheumatology Patients Treated with Certolizumab Pegol: Results From a Usability Study

Barbara Domańska   1 * , MSc ;   Stijn Vansant   2 * , MSc ;   Irina Mountian   2 * , MD, PhD

1 UCB Pharma, Slough, United Kingdom

2 UCB Pharma, Brussels, Belgium

*all authors contributed equally

Corresponding Author: